The case for treating hypercholesterolemia at an earlier age: Moving toward consensus

Journal of the American College of Cardiology

Volumn 60, Issue 25, 2012, Pages 2640-2642

  Steinberg, Daniel ^a   Grundy, Scott M ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

atherosclerosis; coronary heart disease; hypercholesterolemia; randomized clinical trials; risk factors; treatment guidelines

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; SIMVASTATIN;

ATHEROGENESIS; EARLY INTERVENTION; FAMILIAL HYPERCHOLESTEROLEMIA; FRAMINGHAM RISK SCORE; GENE; GENETIC POLYMORPHISM; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LOSS OF FUNCTION MUTATION; NONSENSE MUTATION; NOTE; PCSK9 GENE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION;

EID: 84871324261     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.09.016     Document Type: Editorial

References (24)

1. H.C. McGill Jr., C.A. McMahan Determinants of atherosclerosis in the young Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group Am J Cardiol 82 1998 30T 36T
2. G.S. Berenson, S.R. Srinivasan, W. Bao, W.P. Newman 3rd, R.E. Tracy, W.A. Wattigney Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults The Bogalusa Heart Study N Engl J Med 338 1998 1650 1656 (Pubitemid 28267909)
3. H.C. Stary, A.B. Chandler, S. Glagov A definition of initial, fatty streak, and intermediate lesions of atherosclerosis A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Arterioscler Thromb 14 1994 840 856
4. G.T. Malcom, M.C. Oalmann, J.P. Strong Risk factors for atherosclerosis in young subjects: the PDAY Study Pathobiological Determinants of Atherosclerosis in Youth Ann N Y Acad Sci 817 1997 179 188 (Pubitemid 27344648)
5. O.T. Raitakari, M. Juonala, M. Kahonen Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study JAMA 290 2003 2277 2283 (Pubitemid 37430560)
6. R.W. Wissler An overview of the quantitative influence of several risk factors on progression of atherosclerosis in young people in the United States Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group Am J Med Sci 310 Suppl 1 1995 S29 S36
7. J. Cohen, A. Pertsemlidis, I.K. Kotowski, R. Graham, C.K. Garcia, H.H. Hobbs Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9 Nat Genet 37 2005 161 165
8. M. Abifadel, M. Varret, J.P. Rabes Mutations in PCSK9 cause autosomal dominant hypercholesterolemia Nat Genet 34 2003 154 156 (Pubitemid 36666925)
9. R. McPherson, N. Kavaslar Statins for primary prevention of coronary artery disease Lancet 369 2007 1078 (Pubitemid 46483653)
10. S. Kathiresan A PCSK9 missense variant associated with a reduced risk of early-onset myocardial infarction N Engl J Med 358 2008 2299 2300 (Pubitemid 351724483)
11. B.A. Ference, W. Yoo, I. Alesh Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis J Am Coll Cardiol 60 2012 2631 2639
12. D. Steinberg, C.K. Glass, J.L. Witztum Evidence mandating earlier and more aggressive treatment of hypercholesterolemia Circulation 118 2008 672 677
13. D.M. Lloyd-Jones, P.W. Wilson, M.G. Larson Framingham risk score and prediction of lifetime risk for coronary heart disease Am J Cardiol 94 2004 20 24 (Pubitemid 38813447)
14. D.M. Lloyd-Jones, E.P. Leip, M.G. Larson Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 2006 791 798
15. M. Domanski, D. Lloyd-Jones, V. Fuster, S. Grundy Can we dramatically reduce the incidence of coronary heart disease? Nat Rev Cardiol 8 2011 721 725
16. D. Steinberg Earlier intervention in the management of hypercholesterolemia: what are we waiting for? J Am Coll Cardiol 56 2010 627 629
17. H.C. Gooding, S.D. de Ferranti Cardiovascular risk assessment and cholesterol management in adolescents: getting to the heart of the matter Curr Opin Pediatr 22 2010 398 404
18. C.J. McNeal, T. Dajani, D. Wilson, A.E. Cassidy-Bushrow, J.B. Dickerson, M. Ory Hypercholesterolemia in youth: opportunities and obstacles to prevent premature atherosclerotic cardiovascular disease Curr Atheroscler Rep 12 2010 20 28
19. M.J. Braamskamp, F.A. Wijburg, A. Wiegman Drug therapy of hypercholesterolaemia in children and adolescents Drugs 72 2012 759 772
20. C. Baigent, A. Keech, P.M. Kearney Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
21. Cholesterol Treatment Trialists' (CTT) Collaborators B. Mihaylova, J. Emberson, L. Blackwell et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials Lancet 380 2012 581 590
22. H.J. Avis, B.A. Hutten, C. Gagne Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia J Am Coll Cardiol 55 2010 1121 1126
23. D.M. Lloyd-Jones, P.W. Wilson, M.G. Larson Lifetime risk of coronary heart disease by cholesterol levels at selected ages Arch Intern Med 163 2003 1966 1972 (Pubitemid 37082710)
24. M.R. Law, N.J. Wald, S.G. Thompson By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 308 1994 367 372 (Pubitemid 24078498)